[ET Net News Agency, 14 March 2025] JXR (01951) rose 31.3% to HK$3.31, breaking above
the 250-D SMA of HK$2.788.
It hits an intra-day high of HK$3.31, hitting an 1-month high, and an intra-day low of
HK$2.58. The total shares traded was 428.11 million, with a value of HK$1.27b. The active
buy/sell ratio is 65:35, with net buying turnover of HK$383.41m. BARCLAYS CAPITAL ASIA
accounts for greatest net responsive buying turnover of HK$9.49m, with volume weighted
average price of HK$2.876. CHINA INV INFO accounts for greatest net responsive selling
turnover of HK$100.65m, with volume weighted average price of HK$2.967.

Basic Information
=================

-----------------------------------
Nominal 3.310 % Chg +31.35%
High 3.310 Low 2.580
Shares Tr 428.11m Turnover 1.27b
10-D SMA 2.681 %H.V 47.711
20-D SMA 2.726 VWAP 2.977
50-D SMA 2.620 RSI14 72.393
-----------------------------------
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is
65:35, with net buying turnover of HK$383.41m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
JXR (01951) 3.31 +31.35
SIPAI HEALTH (00314) 5.09 +3.46
CR MEDICAL (01515) 4.27 +2.89
FOSUN PHARMA (02196) 15.40 +3.36
CHAOJU EYE CARE (02219) 3.15 +2.27
RIMAG GROUP (02522) 32.30 -2.71
C-MER MEDICAL (03309) 1.69 +0.60
HYGEIA HEALTH (06078) 14.20 +5.34
FANGZHOU JIANKE (06086) 5.13 -7.40
YSB (09885) 6.89 +3.61
-----------------------------------------------
(ed)